News

27 Jul
 
Panexcell Clinical Laboratories: suspension of medicines over flawed studies
27 Jul
 
FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL
27 Jul
 
The ADA at 30: the Importance of Law and Health Policy in Expanding Equity
27 Jul
 
WHO statement on heated tobacco products and the US FDA decision regarding IQOS
27 Jul
 
World Hepatitis Day: fast-tracking the elimination of hepatitis B among mothers and children
24 Jul
 
New country support package launched to accelerate salt reduction in the WHO European Region
24 Jul
 
FDA Requiring Labeling Changes for Opioid Pain Medicines, Opioid Use Disorder Medicines Regarding Naloxone
23 Jul
 
Canada Invests in Smart Grid Technology for London Net-Zero Energy Community
23 Jul
 
Countries commit to meeting SDGs in face of pandemic
23 Jul
 
Over 10 000 health workers in Africa infected with COVID-19
23 Jul
 
Government of Canada invests $5.7M in new research network to study deadly blood infections
23 Jul
 
FDA Proposes New Rule on Reporting Requirements
22 Jul
 
WHO Regional Director for Europe signs agreement for new centre of excellence and visits Gaziantep, marking 60 years of cooperation with Turkey
22 Jul
 
V-MAX Herbal Tablets
22 Jul
 
COVID-19: EMA sets up infrastructure for real-world monitoring of treatments and vaccines
22 Jul
 
Salmonella Investigation Notice
22 Jul
 
U.S. Government Engages Pfizer to Produce Millions of Doses of COVID-19 Vaccine
22 Jul
 
HHS Announces National COVID-19 Testing Implementation Forum
22 Jul
 
New COVID-19 Law Lab to provide vital legal information and support for the global COVID-19 response
21 Jul
 
FDA Extends Enforcement Discretion Policy for Certain Regenerative Medicine Products
21 Jul
 
WHO helps reshape hospitals as COVID-19 eases its grip
21 Jul
 
OCR Issues Guidance on Civil Rights Protections Prohibiting Race, Color, and National Origin Discrimination During COVID-19
20 Jul
 
Women leaders call for integrating mental health into COVID-19 response
20 Jul
 
One million patients reported as recovered from COVID-19 in WHO’s Eastern Mediterranean Region
20 Jul
 
FDA Notifies Companies, Including Puff Bar, to Remove Flavored Disposable E-Cigarettes and Youth-Appealing E-Liquids from Market for Not Having Required Authorization

Clinical Research News

Kommende kliniske forsøg

Abonner